If you're looking to add some new shares to your portfolio in April, then you might want to take a look at the ones listed below.
They could be among the best on the market and destined to deliver strong growth over the 2020s. Here's why they are rated highly:
Afterpay Ltd (ASX: APT)
The first ASX share to consider is Afterpay. Due to the increasing popularity of its buy now pay later platform and its global expansion, the payments company looks exceptionally well-positioned for growth over the 2020s. In respect to its expansion, Afterpay has just launched in Canada, is launching in mainland Europe shortly, and is looking closely at the Asia market. Combined with its $5 trillion opportunity in the United States, the future looks bright for the company.
Morgan Stanley currently has an overweight rating and $149.00 price target on its shares.
Pushpay Holdings Group Ltd (ASX: PPH)
Another ASX share to consider buying is Pushpay. It is a donor management and community engagement platform provider for the faith sector. Thanks to the shift to a cashless society and social distancing measures, Pushpay's platform is proving invaluable for churches. This has led to it delivering stellar sales growth over the last few years. And thanks to operating leverage, its earnings have been growing at an even quicker rate.
Goldman Sachs is a fan of Pushpay and has a conviction buy rating and $2.59 price target on its shares.
ResMed Inc. (ASX: RMD)
A final ASX share to consider is ResMed. This sleep treatment-focused medical device company appears well-placed for growth thanks to its industry-leading products and sizeable market opportunity. ResMed also has a growing ecosystem of connected devices generating invaluable data insights. This could give it a real edge over the competition in the future and puts it in a great position to benefit from the shift to home healthcare.
Bell Potter is positive on ResMed's outlook. It currently has a buy rating and $29.00 price target on its shares.
